COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
Bill of Health
JANUARY 12, 2023
By 2009, before Moderna’s patent application, scientists knew that the full-length spike protein is highly immunogenic and can be used to induce protection against certain viruses. government committed more than one billion dollars to Moderna for development of its COVID-19 vaccines. Indeed, as made public, the U.S.
Let's personalize your content